CryoLife to Present at Two Investor Conferences in November 2016

ATLANTA, Nov. 10, 2016 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that Pat Mackin, Chairman, President and Chief Executive Officer, will present at two investor conferences in November 2016.

The first conference is the Canaccord Genuity Medical Technologies and Diagnostics Forum in New York.

Event: Canaccord Genuity Medical Technologies and Diagnostics ForumDate: Thursday, November 17, 2016Time: 8:00 a.m. ET

The second conference is the 28th Annual Piper Jaffray Healthcare Conference in New York.

Event: 28th Annual Piper Jaffray Healthcare ConferenceDate: Tuesday, November 29, 2016Time: 4:00 p.m. ET

The live webcast of the Company's presentations can be accessed through CryoLife's website, www.cryolife.com, on the Investor Relations page.  An archived copy of the webcasts will be available for 90 days on the same website.

About CryoLife

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac surgical procedures.  CryoLife markets and sells products in more than 80 countries worldwide.  For additional information about CryoLife, visit our website, www.cryolife.com.

Logo - http://photos.prnewswire.com/prnh/20140319/MM86518LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cryolife-to-present-at-two-investor-conferences-in-november-2016-300360519.html

SOURCE CryoLife, Inc.